Padfield P L, Morton J J
J Endocrinol. 1977 Aug;74(2):251-9. doi: 10.1677/joe.0.0740251.
Studies were designed to determine whether angiotensin II has a direct stimulatory effect on arginine-vasopressin in man and to determine the role, if any, played by angiotensin II in the control of vasopressin release in physiological and pathological conditions. Acute infusion of angiotensin II in normal volunteers produced small but definite increases in plasma levels of arginine-vasopressin (5-4+/-0-3(S.E.M.) to 6-4+/-0-2 pg/ml) only when plasma angiotensin II levels were supraphysiological. Concurrent measurements of plasma arginine-vasopressin and angiotensin II were made during acute changes in fluid balance and posture in normal volunteers and in clinical conditions characterized by high plasma levels of angiotensin II (Addison's disease and Bartter's syndrome). The results of these studies allow us to conclude that there is little to suggest a direct effect of angiotensin II which is likely to be relevant to the normal physiological control of arginine-vasopressin in man.
开展这些研究旨在确定血管紧张素II对人体精氨酸加压素是否具有直接刺激作用,并确定血管紧张素II在生理和病理状态下控制加压素释放过程中所起的作用(若有)。仅在血浆血管紧张素II水平高于生理水平时,向正常志愿者急性输注血管紧张素II才会使血浆精氨酸加压素水平出现小幅但确切的升高(从5.4±0.3(标准误)皮克/毫升升至6.4±0.2皮克/毫升)。在正常志愿者体液平衡和体位急性改变期间以及以血浆血管紧张素II水平升高为特征的临床病症(艾迪生病和巴特综合征)中,对血浆精氨酸加压素和血管紧张素II进行了同步测量。这些研究结果使我们能够得出结论,几乎没有证据表明血管紧张素II具有直接作用,而这种作用可能与人体精氨酸加压素的正常生理控制相关。